SCHEMBL20797477

SCHEMBL20797477

CCOCCNc1cccc(Cl)c1N

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
POLB P06746 1/20 0.48
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAPK1 P28482 2/20 0.36
NSD2 O96028 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
HSD17B10 Q99714 1/20 0.35
THRB P10828 1/20 0.35
UTS2R Q9UKP6 1/20 0.33
NR4A2 P43354 1/20 0.33
TLR7 Q9NYK1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20797741 0.89 KDM4E (0.39) KDM4EPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL20797370 0.80 SMN1; SMN2 (0.42) KDM4EALDH1A1SMN1; SMN2TDP1MAPK1
SCHEMBL3786366 0.78 ALDH1A1 (0.38) KDM4EPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL7733714 0.77 MAPT (0.45) KDM4EPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL10498572 0.77 PTGER4 (0.40) KDM4EALDH1A1SMN1; SMN2L3MBTL1TDP1
SCHEMBL20797675 0.76 KAT2B (0.44) KDM4EPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL20797542 0.75 P2RX7 (0.40) KDM4EPOLBALDH1A1SMN1; SMN2NPSR1
SCHEMBL24335155 0.72 MAPT (0.46) KDM4EPOLBALDH1A1SMN1; SMN2TDP1
SCHEMBL19049409 0.72 L3MBTL1 (0.50) KDM4EPOLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL10408248 0.71 MAPT (0.64) KDM4EALDH1A1SMN1; SMN2L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019049061-A1 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-03-14 WO disclosed
WO-2019049061-A1 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-03-14 WO disclosed